Audiometers in New Jersey

Oticon Medical is a manufacturer of bone-anchored hearing systems (BAHS) and bone conduction hearing solutions for children and adults with conductive, mixed, or single-sided sensorineural hearing loss. The company is part of the Demant Group and develops implantable and non-invasive hearing devices that bypass damaged portions of the ear to deliver sound directly to the inner ear via bone conduction. Primary product lines include the Ponto system (bone-conduction hearing processors available in multiple generations including Ponto 5 and Ponto 5 SuperPower), the Sentio transcutaneous system, and the Softband for pediatric candidates. Oticon Medical serves audiologists, hearing healthcare professionals, and patients globally through a network of local clinics and representatives. The company provides clinical support, online resources, batteries, and counseling tools through bahsjourney.com. Following the sale of their cochlear implant business in 2024, Oticon Medical remains focused exclusively on bone-anchored hearing aid development and patient support. Products are designed for implantation or transcutaneous use and marketed for use in educational, professional, and social settings. The company maintains regulatory compliance and operates through a global distribution network with localized support in multiple countries including the United States.

WS Audiology USA (WSA) is a global leader in hearing healthcare, designing and manufacturing innovative hearing aids for individuals with mild to profound hearing loss. The company operates through multiple independent brands—Signia, Widex, Rexton, Audio Service, and Vibe—each built on differentiated technology platforms. WSA serves over 130 markets globally and has equipped 3.9 million people with hearing aids as of 2024/25. The company addresses hearing loss across the clinical spectrum: mild hearing loss through consumer over-the-counter (OTC) solutions and professional-fit aids; moderate to severe hearing loss via hearing care professional (HCP) fitted devices; and severe to profound hearing loss through bone-anchored hearing aids (BAHA) and cochlear implants. Product offerings include completely-in-canal (CIC), invisible-in-canal (IIC), receiver-in-canal (RIC), behind-the-ear (BTE), and in-the-ear (ITE) hearing aids, many featuring rechargeable battery technology, Bluetooth connectivity, and advanced sound processing. Recent innovations include the Signia Insio Charge&GO CIC IX (first rechargeable custom CIC with directional microphones), Widex Allure with W1 chip platform, and Signia Active Pro IX combining prescription capabilities with consumer earbud design. WSA employs 12,000+ people across 45+ global offices, with major operations in Denmark (global HQ in Lynge), Singapore (Asia-Pacific hub), and the United States (regional HQ in Iselin, NJ; manufacturing in Tijuana and Long Island). The company maintains 1,200+ engineers across R&D hubs in Erlangen, Hyderabad, and Chicago, supporting 140 years of innovation in hearing technology. Regulatory status and specific FDA/ISO certifications not detailed on the primary homepage.